Agricultural giant Cargill has been ordered to hand over documents to Glencore regarding its use of an unauthorised type of barley before and after its $420 million acquisition of malt producer Joe White.
Vocational training firm Railtrain knowingly and recklessly misled trainees about their rights to be paid as employees, according to an amended court filing by the Rail, Tram, and Bus Industry Union.
From a record-setting funder’s cut to the first call for ‘“proportionality”, last year saw a number of groundbreaking judgments approving class action settlements worth more than half a billion dollars. Here are the 10 biggest settlements of 2018, and the law firms and funders that negotiated them.
Two law firms have launched formal investigations into possible class actions over Sydney’s defective Opal Tower, inviting owners of units in the “crumbling” building to register their interest in joining legal proceedings.
Actor Craig McLachlan will appear in court next month to face charges of indecent assault, four days after trial kicks off in a high-stakes defamation case brought by the actor against Fairfax Media and the ABC over a joint report accusing him of abuse, sexual harassment and assault during the 2014 stage production of the “Rocky Horror Picture Show”.
Online payment giant PayPal has successfully opposed trade mark registration sought by Australian financial planning software company FinPal, with IP Australia finding the -pal suffix to be a “striking similarity” between the two marks.
The families of asylum seekers who died in the 2010 Christmas Island boat crash have lost an appeal of a ruling that dismissed their class action against Australia.
The applicants in a class action over exposure to allegedly toxic foam used on a government military base have struck back at the Commonwealth of Australia’s argument that their claims were filed too late.
A judge has rejected an application by auto electronics maker Redarc Group for an injunction in a case against rival B8 Systems over an innovation patent for its flagship vehicle brake controller, despite its strong case of infringement.
Generic drug maker Sandoz is challenging a ruling that it infringed a patent behind Lundbeck’s blockbuster antidepressant Lexapro, reviving a 15-year fight over the lucrative intellectual property.